Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive Care Medicine, (2024), 50, 1, (68-78), 10.1007/s00134-023-07271-w)

on behalf of the REVIVAL investigators

doi:10.1007/s00134-024-07357-z

Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive Care Medicine, (2024), 50, 1, (68-78), 10.1007/s00134-023-07271-w)

on behalf of the REVIVAL investigators

Emergency Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

After the publication of the article, we have been informed that the name of a contributor in the list of REVIVAL investigators was given incomplete. He was given as “Patrick Honore” or “Honore P” but he should have been cited as “Patrick M. Honore” or “Honore PM”. Additionally, there are two mistakes in the contributors list: “ElisabethDiltoer” should read “Elisabeth Dewaele, Marc Diltoer” and “Craig French” should be also added. The original publication and the supplementary Excel file have been updated. The Authors apologize for these mistakes.

Original language	English (US)
Pages (from-to)	614-615
Number of pages	2
Journal	Intensive Care Medicine
Volume	50
Issue number	4
DOIs	https://doi.org/10.1007/s00134-024-07357-z
State	Published - Apr 2024

ASJC Scopus subject areas

Critical Care and Intensive Care Medicine

Access to Document

10.1007/s00134-024-07357-z

Fingerprint

Dive into the research topics of 'Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive Care Medicine, (2024), 50, 1, (68-78), 10.1007/s00134-023-07271-w)'. Together they form a unique fingerprint.

Cite this

Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive Care Medicine, (2024), 50, 1, (68-78), 10.1007/s00134-023-07271-w). / on behalf of the REVIVAL investigators.
In: Intensive Care Medicine, Vol. 50, No. 4, 04.2024, p. 614-615.

Research output: Contribution to journal › Comment/debate › peer-review

@article{22d117df31344f26bc71bfaa41a90a33,

title = "Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive Care Medicine, (2024), 50, 1, (68-78), 10.1007/s00134-023-07271-w)",

abstract = "After the publication of the article, we have been informed that the name of a contributor in the list of REVIVAL investigators was given incomplete. He was given as “Patrick Honore” or “Honore P” but he should have been cited as “Patrick M. Honore” or “Honore PM”. Additionally, there are two mistakes in the contributors list: “ElisabethDiltoer” should read “Elisabeth Dewaele, Marc Diltoer” and “Craig French” should be also added. The original publication and the supplementary Excel file have been updated. The Authors apologize for these mistakes.",

author = "{on behalf of the REVIVAL investigators} and Peter Pickkers and Angus, {Derek C.} and Kristie Bass and Rinaldo Bellomo and {van den Berg}, Erik and Juliane Bernholz and Bestle, {Morten H.} and Kent Doi and Doig, {Chistopher J.} and Ricard Ferrer and Bruno Francois and Henrik Gammelager and Pedersen, {Ulf Goettrup} and Eric Hoste and Susanne Iversen and Michael Joannidis and Kellum, {John A.} and Kathleen Liu and Melanie Meersch and Ravindra Mehta and Scott Millington and Murray, {Patrick T.} and Alistair Nichol and Marlies Ostermann and Ville Pettil{\"a} and Christoffer Solling and Matthias Winkel and Young, {Paul J.} and Alexander Zarbock and Angus Carter and Dietmar Fries and Philip Eller and Ludovic G{\'e}rard and Nicolas DeSchryver and Elisabeth Diltoer and Vincent Huberlant and Isabelle Michaux and Honore, {Patrick M.} and Tom Fivez and Gordon Wood and John Boyd and Alexis Turgeon and Maj Kamper and Thomas Str{\o}m and Sussanne Iversen and Hendrik Gammelager and Rasmussen, {Bodil Steen} and S{\o}lling, {Christoffer Grant} and M{\ae}ller, {Morten Hyllander} and Jarrod Mosier",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = apr,

doi = "10.1007/s00134-024-07357-z",

language = "English (US)",

volume = "50",

pages = "614--615",

journal = "Intensive Care Medicine",

issn = "0342-4642",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "4",

}

TY - JOUR

T1 - Correction

T2 - Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive Care Medicine, (2024), 50, 1, (68-78), 10.1007/s00134-023-07271-w)

AU - on behalf of the REVIVAL investigators

AU - Pickkers, Peter

AU - Angus, Derek C.

AU - Bass, Kristie

AU - Bellomo, Rinaldo

AU - van den Berg, Erik

AU - Bernholz, Juliane

AU - Bestle, Morten H.

AU - Doi, Kent

AU - Doig, Chistopher J.

AU - Ferrer, Ricard

AU - Francois, Bruno

AU - Gammelager, Henrik

AU - Pedersen, Ulf Goettrup

AU - Hoste, Eric

AU - Iversen, Susanne

AU - Joannidis, Michael

AU - Kellum, John A.

AU - Liu, Kathleen

AU - Meersch, Melanie

AU - Mehta, Ravindra

AU - Millington, Scott

AU - Murray, Patrick T.

AU - Nichol, Alistair

AU - Ostermann, Marlies

AU - Pettilä, Ville

AU - Solling, Christoffer

AU - Winkel, Matthias

AU - Young, Paul J.

AU - Zarbock, Alexander

AU - Carter, Angus

AU - Fries, Dietmar

AU - Eller, Philip

AU - Gérard, Ludovic

AU - DeSchryver, Nicolas

AU - Diltoer, Elisabeth

AU - Huberlant, Vincent

AU - Michaux, Isabelle

AU - Honore, Patrick M.

AU - Fivez, Tom

AU - Wood, Gordon

AU - Boyd, John

AU - Turgeon, Alexis

AU - Kamper, Maj

AU - Strøm, Thomas

AU - Iversen, Sussanne

AU - Gammelager, Hendrik

AU - Rasmussen, Bodil Steen

AU - Sølling, Christoffer Grant

AU - Mæller, Morten Hyllander

AU - Mosier, Jarrod

PY - 2024/4

Y1 - 2024/4

N2 - After the publication of the article, we have been informed that the name of a contributor in the list of REVIVAL investigators was given incomplete. He was given as “Patrick Honore” or “Honore P” but he should have been cited as “Patrick M. Honore” or “Honore PM”. Additionally, there are two mistakes in the contributors list: “ElisabethDiltoer” should read “Elisabeth Dewaele, Marc Diltoer” and “Craig French” should be also added. The original publication and the supplementary Excel file have been updated. The Authors apologize for these mistakes.

AB - After the publication of the article, we have been informed that the name of a contributor in the list of REVIVAL investigators was given incomplete. He was given as “Patrick Honore” or “Honore P” but he should have been cited as “Patrick M. Honore” or “Honore PM”. Additionally, there are two mistakes in the contributors list: “ElisabethDiltoer” should read “Elisabeth Dewaele, Marc Diltoer” and “Craig French” should be also added. The original publication and the supplementary Excel file have been updated. The Authors apologize for these mistakes.

UR - http://www.scopus.com/inward/record.url?scp=85190753980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85190753980&partnerID=8YFLogxK

U2 - 10.1007/s00134-024-07357-z

DO - 10.1007/s00134-024-07357-z

M3 - Comment/debate

C2 - 38436728

AN - SCOPUS:85190753980

SN - 0342-4642

VL - 50

SP - 614

EP - 615

JO - Intensive Care Medicine

JF - Intensive Care Medicine

IS - 4

ER -

Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive Care Medicine, (2024), 50, 1, (68-78), 10.1007/s00134-023-07271-w)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this